NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV 1) - ANVISA Registration 10287411134

Access comprehensive regulatory information for NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV 1) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10287411134 and manufactured by manufacturer not specified. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until Jun 27, 2026.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including CEPHEID AB, ABBOTT MOLECULAR INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.